• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗Pfs230特异性抗体对恶性疟原虫疟疾的传播阻断具有抗体类别依赖性。

Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.

作者信息

Roeffen W, Geeraedts F, Eling W, Beckers P, Wizel B, Kumar N, Lensen T, Sauerwein R

机构信息

Department of Medical Microbiology, University of Nijmegen, The Netherlands.

出版信息

Infect Immun. 1995 Feb;63(2):467-71. doi: 10.1128/iai.63.2.467-471.1995.

DOI:10.1128/iai.63.2.467-471.1995
PMID:7822011
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC173018/
Abstract

By use of the parental hybridoma cell line 63F2A2 that produces specific antibodies of immunoglobulin isotype G1 (IgG1; 63F2A2.1) against Pfs230, we attempted to enrich for the synthesis of the downstream switch variant IgG2b and IgG2a monoclonal antibodies (MAbs) of the hybridoma cell line (63F2A2.2b and 63F2A2.2a, respectively). The parental IgG1 did not reduce the Plasmodium falciparum transmission in a bioassay irrespective of the presence of complement. MAbs 63F2A2.2b and 63F2A2.2a were effective in reducing the infectivity of P. falciparum parasites to Anopheles gambiae mosquitoes in membrane-feeding experiments. A transmission reduction of 91% was accomplished by the 63F2A2.2b switch variant, and a reduction of greater than 99% was accomplished by the 63F2A2.2a switch variant, but only in the presence of active human complement. Subsequently, the transmission-reducing effect of MAb 63F2A2.2b or 63F2A2.2a was confirmed in vitro by the rapid lysis of newly formed macrogametes or zygotes in the presence of active complement. MAb 63F2A2.1 did not lyse the newly formed macrogametes or zygotes irrespective of the presence of complement.

摘要

利用产生针对Pfs230的免疫球蛋白同种型G1(IgG1;63F2A2.1)特异性抗体的亲代杂交瘤细胞系63F2A2,我们试图富集杂交瘤细胞系(分别为63F2A2.2b和63F2A2.2a)下游转换变体IgG2b和IgG2a单克隆抗体(MAb)的合成。亲代IgG1在生物测定中无论是否存在补体都不会降低恶性疟原虫的传播。在膜饲实验中,单克隆抗体63F2A2.2b和63F2A2.2a可有效降低恶性疟原虫对冈比亚按蚊的感染性。63F2A2.2b转换变体实现了91%的传播降低率,63F2A2.2a转换变体实现了大于99%的降低率,但仅在存在活性人补体的情况下。随后,通过在活性补体存在下新形成的大配子或合子的快速裂解,在体外证实了单克隆抗体63F2A2.2b或63F2A2.2a的传播降低效果。无论是否存在补体,单克隆抗体63F2A2.1都不会裂解新形成的大配子或合子。

相似文献

1
Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.抗Pfs230特异性抗体对恶性疟原虫疟疾的传播阻断具有抗体类别依赖性。
Infect Immun. 1995 Feb;63(2):467-71. doi: 10.1128/iai.63.2.467-471.1995.
2
Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing.针对恶性疟原虫配子表面抗原Pfs230多个非变异靶表位的传递阻断抗体均具有补体固定作用。
Parasite Immunol. 1994 Oct;16(10):511-9. doi: 10.1111/j.1365-3024.1994.tb00305.x.
3
Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.疟疾免疫个体对恶性疟原虫的传播阻断免疫与针对配子表面蛋白Pfs230的抗体有关。
Parasitology. 1999 Nov;119 ( Pt 5):425-33. doi: 10.1017/s0031182099005041.
4
The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.恶性疟原虫的230-kDa配子体表面蛋白也是传播阻断抗体的靶标。
J Immunol. 1987 Dec 15;139(12):4213-7.
5
Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.恶性疟原虫:在传播阻断免疫测定和特异性竞争酶联免疫吸附测定中Pfs230特异性抗体活性的比较
Exp Parasitol. 1995 Feb;80(1):15-26. doi: 10.1006/expr.1995.1003.
6
ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.通过标准的恶性疟原虫膜饲法判断,酶联免疫吸附测定(ELISA)单位、IgG亚类比例和亲和力可确定小鼠抗Pfs230抗体的功能活性。
Vaccine. 2019 Apr 3;37(15):2073-2078. doi: 10.1016/j.vaccine.2019.02.071. Epub 2019 Mar 5.
7
Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity.恶性疟原虫有性阶段抗原Pfs230特定区域诱导疟疾传播阻断免疫的差异能力。
Parasite Immunol. 2000 Aug;22(8):373-80. doi: 10.1046/j.1365-3024.2000.00315.x.
8
Comparison of serological tests and bio-assay for malaria transmission blocking capacity in field sera.现场血清中疟疾传播阻断能力的血清学检测与生物测定的比较。
Parassitologia. 1993 Jul;35 Suppl:95-7.
9
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.用一种疟疾传播阻断候选疫苗Pfs25进行鼻腔免疫,可在小鼠中诱导出针对恶性疟原虫野外分离株的完全保护性免疫。
Infect Immun. 2005 Nov;73(11):7375-80. doi: 10.1128/IAI.73.11.7375-7380.2005.
10
Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi.经有效 TLR 佐剂配方制成的动合子和子孢子穿透蛋白(CelTOS)可诱导产生高亲和力抗体,从而抑制冈比亚按蚊感染疟原虫。
Malar J. 2019 Apr 24;18(1):146. doi: 10.1186/s12936-019-2773-3.

引用本文的文献

1
Magnitude and durability of ProC6C-AlOH/Matrix-M vaccine-induced malaria transmission-blocking antibodies in Burkinabe adults from a Phase 1 randomized trial.1期随机试验中,ProC6C-AlOH/Matrix-M疫苗在布基纳法索成年人中诱导产生的疟疾传播阻断抗体的强度和持久性
Hum Vaccin Immunother. 2025 Dec;21(1):2488075. doi: 10.1080/21645515.2025.2488075. Epub 2025 Apr 10.
2
Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies.内源性Pfs230与Pfs48/45和强效疟疾传播阻断抗体形成的复合物的结构
bioRxiv. 2025 Feb 15:2025.02.14.638310. doi: 10.1101/2025.02.14.638310.
3
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.针对疟疾传播的瓶颈:抗体-表位描述指导下一代生物医学干预措施的设计。
Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.
4
A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity.一种自组装的Pfs230D1-铁蛋白纳米颗粒疫苗具有强大且持久的减少疟疾传播活性。
Vaccines (Basel). 2024 May 16;12(5):546. doi: 10.3390/vaccines12050546.
5
Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody.Pfs230结构域7是一种强效疟疾传播阻断单克隆抗体的作用靶点。
NPJ Vaccines. 2023 Dec 12;8(1):186. doi: 10.1038/s41541-023-00784-x.
6
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle.一种由单组分60拷贝Pfs230D1纳米颗粒设计而成的高效且持久的疟疾传播阻断疫苗。
NPJ Vaccines. 2023 Aug 18;8(1):124. doi: 10.1038/s41541-023-00709-8.
7
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.来自自然感染个体的强效传播阻断单克隆抗体靶向恶性疟原虫 Pfs230 上的保守表位。
Immunity. 2023 Feb 14;56(2):420-432.e7. doi: 10.1016/j.immuni.2023.01.013.
8
Deceiving and escaping complement - the evasive journey of the malaria parasite.欺骗与逃避补体——疟原虫的迂回之旅。
Trends Parasitol. 2022 Nov;38(11):962-974. doi: 10.1016/j.pt.2022.08.013. Epub 2022 Sep 8.
9
6-Cysteine Proteins: Functional Diversity, Transmission-Blocking Antibodies and Structural Scaffolds.6-半胱氨酸蛋白:功能多样性、阻断传播的抗体和结构支架。
Front Cell Infect Microbiol. 2022 Jul 8;12:945924. doi: 10.3389/fcimb.2022.945924. eCollection 2022.
10
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes.单克隆抗体可阻断多种基因不同的恶性疟原虫菌株向蚊子的传播。
NPJ Vaccines. 2021 Aug 12;6(1):101. doi: 10.1038/s41541-021-00366-9.

本文引用的文献

1
Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.
J Immunol. 1993 Dec 15;151(12):7077-85.
2
Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated.人类对恶性疟原虫有性阶段特异性表面抗原Pfs 230的抗体反应:无反应性是一种稳定的表型,但似乎不受基因调控。
Parasite Immunol. 1994 Feb;16(2):55-62. doi: 10.1111/j.1365-3024.1994.tb00323.x.
3
Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka.在斯里兰卡这种低流行率情况下的恶性疟原虫疟疾传播阻断免疫力。
Parasite Immunol. 1994 Jan;16(1):35-42. doi: 10.1111/j.1365-3024.1994.tb00302.x.
4
Mutational events in mouse myeloma cells.小鼠骨髓瘤细胞中的突变事件。
Crit Rev Immunol. 1981 Sep;3(1):1-22.
5
Isolation of variants of mouse myeloma X63 that express changed immunoglobulin class.表达免疫球蛋白类别改变的小鼠骨髓瘤X63变体的分离。
Proc Natl Acad Sci U S A. 1980 May;77(5):2909-13. doi: 10.1073/pnas.77.5.2909.
6
Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures.
Trans R Soc Trop Med Hyg. 1982;76(6):812-8. doi: 10.1016/0035-9203(82)90116-x.
7
Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.针对鸡疟原虫配子表面决定簇的单克隆抗体可阻断疟原虫向蚊子的传播。
J Immunol. 1983 Nov;131(5):2557-62.
8
Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay.补体亚成分C1q与小鼠IgG1、IgG2a和IgG2b的结合:一种新型C1q结合测定法。
Mol Immunol. 1984 Apr;21(4):321-7. doi: 10.1016/0161-5890(84)90103-2.
9
Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum.恶性疟原虫配子体上传播阻断免疫的靶抗原
J Exp Med. 1983 Sep 1;158(3):976-81. doi: 10.1084/jem.158.3.976.
10
Isolation of immunoglobulin class switch variants from hybridoma lines secreting anti-idiotope antibodies by sequential sublining.通过连续亚克隆从分泌抗独特型抗体的杂交瘤细胞系中分离免疫球蛋白类别转换变体。
J Immunol. 1983 Aug;131(2):877-81.